Literature DB >> 567267

The sublabial transseptal transsphenoidal approach to the hypophysis.

K J Lee.   

Abstract

A simple and safe technique for the sublabial transseptal transsphenoidal approach to the hypophysis and parasellar region is described. A review of the literature reveals that this technique and other transsphenoidal routes to the hypophysis were performed more than half a century ago.These procedures fell into disfavor because fo low magnification and insufficient illumination of the operative field, infection and inadequate postoperative endocrine replacement therapy. With today's antibiotic therapy and hormonal replacement, plus the use of the operating microscope, the transsphenoidal route to the hypophysis has gained renewed interest among neurosurgeons and otolaryngologists. Each of the transsphenoidal routes and the advantages of the "from below" approach are described. The applications of transsphenoidal approach and the nonsurgical modalities for hypophysectomy are reviewed. The simplicity and safety of the sublabial transseptal transsphenoidal approach depend on a thorough familiarity with the surgical anatomy, proper positioning of the patient, and the availability of appropriate instrumentation. Photographs of specially prepared whole head anatomical specimens plus skull dissections with radiographic correlation illustrate the pertinent anatomy. Some of the vital structures to be identified and avoided are the optic canals, carotid arteries, circular sinuses, cavernous sinuses, III, IV, V, VI cranial nerves, foramen rotundum, medial walls of the orbits, medial walls of maxillary sinuses, medial pterygoid plates and pterygoid canals. A method for preoperative determination of key distances within the patient's skull is described along with other preoperative tests. This paper discusses the self-retaining speculum and other new instruments for this procedure. A gauge mounted on the front end of the speculum is calibrated to measure the size of the opening at the tip of the speculum. Thirty cases are included in this report, six of which are presented in detail. No operative mortality, CSF rhinorrhea, visual damage carotid or cavernous sinus hemorrhage fracture of the medial pterygoid plates or maxilla were encountered in this series. Three patients developed diabetes insipidus and two patients had meningitis which responded to antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 567267

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  7 in total

1.  Treatment of ruptured ICA during transsphenoidal surgery. Two different endovascular strategies in two cases.

Authors:  S B Ghatge; D B Modi
Journal:  Interv Neuroradiol       Date:  2010-03-25       Impact factor: 1.610

2.  Transpalatal transsphenoidal approach to the sella in children.

Authors:  D E Mattox; B S Carson
Journal:  Skull Base Surg       Date:  1991

3.  Doubled foramen rotundum and maxillary nerve fenestration.

Authors:  Mugurel Constantin Rusu
Journal:  Surg Radiol Anat       Date:  2011-04-05       Impact factor: 1.246

4.  Nasal complication after transsphenoidal surgery for pituitary pathologies.

Authors:  J Nabe-Nielsen
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

5.  Treatment of iatrogenic internal carotid artery laceration and carotid cavernous fistula with endovascular stent-graft placement.

Authors:  Naci Kocer; Osman Kizilkilic; Sait Albayram; Ibrahim Adaletli; Fatih Kantarci; Civan Islak
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

Review 6.  Pituitary adenomas: historical perspective, surgical management and future directions.

Authors:  Debebe Theodros; Mira Patel; Jacob Ruzevick; Michael Lim; Chetan Bettegowda
Journal:  CNS Oncol       Date:  2015-10-26

Review 7.  Management of carotid artery injury in endonasal surgery.

Authors:  Vikram Padhye; Rowan Valentine; Peter-John Wormald
Journal:  Int Arch Otorhinolaryngol       Date:  2014-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.